[{"bbox": [89, 97, 370, 134], "category": "Page-header", "text": "Q-Line Biotech Limited"}, {"bbox": [89, 170, 1563, 396], "category": "Text", "text": "to its existing registered trademarks and the same is pending at the office of the registrar of trademark. Further, our Company is yet to make an application with the Trademark Registry for reflecting the present name of the Company for some of our existing registered trademarks. There can be no assurance that our trademarks will not be adversely affected in the future by actions that are beyond our control including client complaints in relation to intellectual property rights infringement, intellectual property infringements or adverse publicity from any other source in India and abroad. Any damage to our brand name, if not immediately and sufficiently remedied, could have an adverse effect on our reputation, competitive position in India and abroad, business, financial condition, results of operations and cash flows."}, {"bbox": [89, 423, 1563, 811], "category": "Text", "text": "While we take care to ensure that we comply with the intellectual property rights of others, we cannot determine with certainty whether we are infringing any existing third-party intellectual property rights which may force us to alter our offerings. We may also be susceptible to objections and claims from third parties asserting infringement and other related claims. While we have not been subject to any such material claims in the past three Fiscals, any such claims raised in the future could result in costly litigation, divert management's attention and resources, subject us to significant liabilities and require us to enter into potentially expensive royalty or licensing agreements or to cease certain offerings. Further, necessary licenses may not be available to us on satisfactory terms, if at all. Any of the foregoing could have an adverse effect on our business, results of operations, cash flows and financial condition. If claims or actions are adjudicated against us from third parties asserting infringement and other related claims in India and abroad, we may be required to obtain a license, modify our existing technology or cease the use of such technology and design, or use a new non-infringing technology. In addition, we may decide to settle a claim or action against us, the settlement of which could be costly and time consuming. We may also be liable for any past infringement. Any of the foregoing could adversely affect our business, financial condition, results of operations and cash flows."}, {"bbox": [89, 839, 1563, 1035], "category": "Text", "text": "The application of laws governing intellectual property rights in India is uncertain, evolving and could involve substantial risks to us. Further, if we are unable to register our intellectual properties for any reason, including our inability to remove objections to any trademark application, we may not be able to claim registered ownership of such trademark, and as a result, we may not be able to seek remedies for infringement of those trademarks by third parties, which would cause damage to our business prospects, reputation and goodwill in India and abroad. For details, see \"Our Business - Intellectual Property\" and \"Government and Other Approvals\" on pages 123 and 270."}, {"bbox": [89, 1063, 1563, 1165], "category": "List-item", "text": "**21. Our operations depend on the availability of skilled employees, machine operators, scientist and technicians with expertise in healthcare sector. Inability to attract or retain such personnel may affect manufacturing, R&D process which may impact financial condition, cash flow and future growth.**"}, {"bbox": [89, 1191, 1563, 1451], "category": "Text", "text": "The successful manufacturing and production of reagent and machines depends significantly on the availability of skilled employees, machine operators, scientist and technicians with expertise in healthcare sector. Given the technical complexity and safety-critical nature, our workforce is required to possess specialized knowledge and training aligned with industry standards. There is a limited pool of personnel which may possess such expertise specific to our process. We may face risks related to attracting these skilled personnel and retaining these key technical employees. While we have implemented internal training programs and offer development opportunities to attract and retain talent, there can be no assurance that these measures will be sufficient. Any prolonged shortage or high turnover of skilled personnel could impact our ability to meet project timelines, comply with technical specifications, or take on new business opportunities, which in turn may adversely affect our operational performance and long-term growth prospects."}, {"bbox": [89, 1477, 1563, 1579], "category": "List-item", "text": "**22. Our Subsidiaries/Associate, Q-line Innovations Private Limited and Q-line IRIS Private Limited have incurred losses in Fiscal 2025, 2024 and Fiscal 2023, respectively, and may do so in the future, which could have a material adverse effect on our business, prospects, financial condition, cash flows and results of operations.**"}, {"bbox": [89, 1607, 1563, 1736], "category": "Text", "text": "Our Subsidiaries/Associate entities namely Q-line Innovations Private Limited and Q-line IRIS Private Limited have incurred losses in the Fiscal 2025, 2024, respectively. For details of the key financial information of the Subsidiaries, please see \"*our subsidiaries*\" on page 318. The table below sets forth details in relation to the losses incurred by our Subsidiaries/Associate during Fiscal 2025, 2024:"}, {"bbox": [1422, 1736, 1560, 1767], "category": "Text", "text": "(â‚¹ in lakhs)"}, {"bbox": [91, 1765, 1560, 1869], "category": "Table", "text": "<table><thead><tr><td>Name of the Company</td><td>March 2025</td><td>March 2024</td></tr></thead><tbody><tr><td>Q-line Innovations Private Limited</td><td>(36.40)</td><td>-</td></tr><tr><td>Q-line IRIS Private Limited</td><td>(2.05)</td><td>(0.45)</td></tr></tbody></table>"}, {"bbox": [89, 1899, 1563, 2063], "category": "Text", "text": "We may be required to fund the operations of our Subsidiaries/Associate in the future and our investments in our Subsidiaries/Associate may eventually be written-off, which could subject us to additional liabilities and could have an adverse effect on our Company's reputation, profitability and financial condition. In order to continue their operations, our Subsidiaries may require continual financial support from our Company either as debt or as equity. We may not have the ability to provide such support on a continual basis. Such financial support is also subject to limitation under applicable Indian laws."}]